These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32620941)

  • 1. New data emerging on outcomes for patients with COVID-19 and rheumatic diseases.
    Onuora S
    Nat Rev Rheumatol; 2020 Aug; 16(8):407. PubMed ID: 32620941
    [No Abstract]   [Full Text] [Related]  

  • 2. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
    Wallace ZS; Bhana S; Hausmann JS; Robinson PC; Sufka P; Sirotich E; Yazdany J; Grainger R
    Rheumatology (Oxford); 2020 Jun; 59(6):1204-1206. PubMed ID: 32374851
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of Rheumatic Diseases during the COVID-19 Pandemic: Beyond Telehealth Services].
    Fernandes AL; Silva C; Miranda LC
    Acta Med Port; 2020 Oct; 33(10):706. PubMed ID: 32840207
    [No Abstract]   [Full Text] [Related]  

  • 4. How did COVID-19 pandemic changed the Portuguese rheumatology?
    Vieira-Sousa E; Fonseca JE; Santos MJ
    Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
    Robinson PC; Yazdany J
    Nat Rev Rheumatol; 2020 Jun; 16(6):293-294. PubMed ID: 32242121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.
    Mukusheva Z; Assylbekova M; Poddighe D
    Rheumatol Int; 2020 Aug; 40(8):1351-1352. PubMed ID: 32514608
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
    Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
    Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
    Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
    Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
    [No Abstract]   [Full Text] [Related]  

  • 11. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and rheumatology: is shielding really necessary?
    Amani L; Warraich R; Patel N; Tahir H
    Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.
    Ruffer N; Knitza J; Krusche M
    Rheumatol Int; 2020 Dec; 40(12):2031-2037. PubMed ID: 32995894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Reflections on rheumatological aspects of COVID-19.
    Calabrese LH; Calabrese C
    Curr Opin Rheumatol; 2020 Sep; 32(5):427-428. PubMed ID: 32675718
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease.
    Kow CS; Hasan SS
    Rheumatol Int; 2020 Dec; 40(12):2117-2118. PubMed ID: 33044704
    [No Abstract]   [Full Text] [Related]  

  • 16. Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.
    Kim HS; Lee MS; Kim H; Sung YK; Lee J; Shim SC; Park SH; Baek HJ
    Rheumatol Int; 2020 Aug; 40(8):1347-1349. PubMed ID: 32488428
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19.
    Lu C; Li S; Liu Y
    Ann Rheum Dis; 2020 Jun; 79(6):737-739. PubMed ID: 32295789
    [No Abstract]   [Full Text] [Related]  

  • 18. How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.
    Jessica Chang TY; Pope JE
    Immunotherapy; 2020 Oct; 12(15):1115-1119. PubMed ID: 32640861
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and ethnicity: challenges in rheumatology.
    Kumar K; Dubey S; Samanta A; Bosworth A; Moorthy A
    Rheumatology (Oxford); 2020 Aug; 59(8):1802-1803. PubMed ID: 32711403
    [No Abstract]   [Full Text] [Related]  

  • 20. Diversifying online rheumatology education options in the era of COVID-19.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Dec; 39(12):3533-3534. PubMed ID: 33074392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.